Lifeline Therapeutics (fka LFLT)

[Steeley]

23-Jun-2005 3:55pm

Regulation FD Disclosure



ITEM 7.01. Regulation FD.
Lifeline Therapeutics, Inc. (the "Company") intends to disclose the following information to certain investors and other members of the public on or after June 24, 2005:

For the period between June 1, 2005 and June 17, 2005 the Company's total gross sales exceeded $1.5 million, without allowances for returns and defective product. The Company believes that the increase in its gross sales during this time period is primarily attributable to increased exposure in the national media. The Company does not expect either this increased exposure in the national media or the current rate of sales to continue for the immediate future.

More information about the Company and Protandim™ can be found on our website at www.protandim.com.


http://biz.yahoo.com/e/050623/lflt.ob8-k.html